Pilot Study to Understand the Feasibility of Implementing a Wearable Device Cueing System Following Bone Marrow Transplant
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- Pilot evaluation of intervention efficacy
研究概览
简要总结
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
详细描述
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay.
Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move.
Aim 2. To receive participant feedback on their experience participating in the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least 18 years of age
- •Diagnosed with hematologic malignancy
- •Scheduled to receive an alloBMT
- •Physician consent to participate in the study
排除标准
- •Inability to complete 15 minutes walking unassisted
结局指标
主要结局
Pilot evaluation of intervention efficacy
时间窗: cumulative percent from day 1 through discharge from hospital, on average day 30
Efficacy will be evaluated by examining the percentage of time participants responded to the cued exercise prompts.
Patient feedback from participation in the study
时间窗: day 10
Patient experience will be evaluated by looking at the central tendencies of the ratings from the post-participation evaluation survey.
次要结局
未报告次要终点
研究者
Whitney Morelli
Principal Investigator
Medical College of Wisconsin